APP-FUBINACA
APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug.[1] Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested.[2] It contains a phenylalanine amino acid residue in its structure.
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C24H21FN4O2 |
| Molar mass | 416.456 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Legality
Sweden's public health agency suggested to classify APP-FUBINACA as hazardous substance on March 24, 2015.[3]
gollark: *Who is Max Utter?*
gollark: If Dale is to be webscale, it should store them as JSON.
gollark: You mean length-terminated.
gollark: Imagine playing 2D chess without multiversal time travel.
gollark: You're quite literally ext4.
See also
References
- "APP-FUBINACA". Cayman Chemical. Retrieved 15 July 2015.
- Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106982
- "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 16 July 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.